Take Control of Your Health with Advanced Genetic Cancer Screening
When facing concerns about blood disorders or gastrointestinal conditions, having clear answers can bring immense peace of mind. Our PDGFR Alpha Gene Rearrangement FISH test provides the precise genetic information needed to guide your healthcare journey with confidence and clarity.
Understanding Your PDGFR Alpha Gene Test
The PDGFR Alpha Gene Rearrangement test uses advanced FISH (Fluorescence In Situ Hybridization) technology to examine your genetic material for specific abnormalities at chromosome location 4q12. This isn’t just another blood test – it’s a sophisticated genetic analysis that looks for rearrangements in the PDGFR Alpha gene, which plays a crucial role in cell growth and division.
When this gene becomes rearranged, it can lead to uncontrolled cell growth, potentially developing into certain types of blood cancers or gastrointestinal stromal tumours (GIST). By detecting these changes early, we can help your medical team create the most effective treatment plan for your specific condition.
Who Should Consider This Important Genetic Screening?
This test is particularly valuable if you’re experiencing:
- Unexplained blood cell abnormalities or persistent low blood counts
- Symptoms suggesting myeloproliferative disorders
- Gastrointestinal issues that may indicate GIST
- Family history of blood cancers or gastrointestinal tumours
- Current diagnosis requiring genetic confirmation for treatment planning
Many patients find that having this genetic information helps reduce uncertainty and provides a clear path forward in their healthcare journey.
Why This Genetic Information Matters for Your Health
Early detection of PDGFR Alpha gene rearrangements can significantly impact your treatment outcomes. This test provides:
- Precise Diagnosis: Confirms specific genetic abnormalities for accurate disease classification
- Treatment Guidance: Helps identify targeted therapies that may be more effective
- Prognostic Information: Provides insights into disease progression and potential outcomes
- Peace of Mind: Reduces uncertainty and anxiety about your condition
- Personalised Care: Enables your healthcare team to tailor treatment specifically to your genetic profile
Understanding Your Test Results
We know waiting for genetic test results can be stressful. That’s why we provide clear, comprehensive reports within just 4 working days. Your results will clearly indicate whether PDGFR Alpha gene rearrangements were detected, and our team is available to help you understand what this means for your health journey.
Remember: A positive result doesn’t define your future – it provides valuable information that empowers you and your medical team to make informed decisions about your care.
Transparent Pricing – Exceptional Value
| Test Option | Regular Price | Special Price | Savings |
|---|---|---|---|
| PDGFR Alpha Gene Rearrangement FISH Test | ZAR 2,000 | ZAR 850 |
This represents exceptional value for advanced genetic testing that could significantly impact your treatment approach and outcomes.
Why Trust Oracle Genomics?
- Nationwide Coverage: Accessible testing centres across Johannesburg, Cape Town, Durban, and Pretoria
- Expert Accuracy: State-of-the-art FISH technology with 99%+ accuracy rates
- Fast Turnaround: Results in just 4 working days from sample receipt
- Professional Expertise: Working closely with oncologists and hematologists nationwide
- Patient-Focused: Empathetic support throughout your testing journey
Take the Next Step in Your Health Journey
Don’t let uncertainty about your genetic health create unnecessary stress. With our special pricing of just ZAR 2,000, now is the perfect time to get the answers you need.
Sample Requirements: 5 mL whole blood OR 4 mL Bone Marrow in Sodium Heparin tubes. Samples accepted daily until 4 PM.
Important: Please bring your completed Chromosome & FISH analysis Requisition Form (Form 17) when providing your sample.
Early detection through genetic screening can make all the difference. Take control of your health today with Oracle Genomics.
